S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80

Lannett Stock Forecast, Price & News

0.00 (-0.09%)
(As of 07/6/2022 05:43 PM ET)
Today's Range
50-Day Range
52-Week Range
112,789 shs
Average Volume
394,703 shs
Market Capitalization
$24.74 million
P/E Ratio
Dividend Yield
Price Target

Lannett MarketRank™ Forecast

Analyst Rating
2.00 Rating Score
943.7% Upside
$6.00 Price Target
Short Interest
15.79% of Float Sold Short
Dividend Strength
News Sentiment
0.42mentions of Lannett in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($1.54) to ($1.33) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.77 out of 5 stars

Medical Sector

744th out of 1,433 stocks

Pharmaceutical Preparations Industry

373rd out of 683 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive LCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

Lannett logo

About Lannett (NYSE:LCI) Stock

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.

LCI Stock News Headlines

Lannett Co. Inc.
See More Headlines

Industry, Sector and Symbol

Pharmaceutical preparations
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
1 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$478.78 million
Cash Flow
$1.13 per share
Book Value
($0.66) per share


Free Float
Market Cap
$24.74 million

Lannett Frequently Asked Questions

Should I buy or sell Lannett stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Lannett stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LCI, but not buy additional shares or sell existing shares.
View analyst ratings for Lannett
or view top-rated stocks.

What is Lannett's stock price forecast for 2022?

1 equities research analysts have issued 12-month price targets for Lannett's shares. Their LCI stock forecasts range from $6.00 to $6.00. On average, they anticipate Lannett's stock price to reach $6.00 in the next year. This suggests a possible upside of 943.7% from the stock's current price.
View analysts' price targets for Lannett
or view top-rated stocks among Wall Street analysts.

How has Lannett's stock performed in 2022?

Lannett's stock was trading at $1.62 at the beginning of the year. Since then, LCI shares have decreased by 64.5% and is now trading at $0.5749.
View the best growth stocks for 2022 here

When is Lannett's next earnings date?

Lannett is scheduled to release its next quarterly earnings announcement on Wednesday, August 24th 2022.
View our earnings forecast for Lannett

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) posted its earnings results on Wednesday, May, 4th. The company reported ($0.41) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.02. The company earned $78.36 million during the quarter, compared to the consensus estimate of $83.65 million.
View Lannett's earnings history

What guidance has Lannett issued on next quarter's earnings?

Lannett issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $335.00 million-$350.00 million, compared to the consensus revenue estimate of $348.67 million.

Who are Lannett's key executives?

Lannett's management team includes the following people:
  • Mr. Timothy C. Crew, CEO & Director (Age 61, Pay $1.03M) (LinkedIn Profile)
  • Mr. John Kozlowski, VP of Fin., CFO & Principal Accounting Officer (Age 50, Pay $531.84k) (LinkedIn Profile)
  • Mr. John M. Abt, VP and Chief Quality & Operations Officer (Age 57, Pay $444.74k)
  • Mr. Samuel H. Israel, Gen. Counsel & Chief Legal Officer (Age 60, Pay $521.95k)
  • Ms. Maureen M. Cavanaugh, Sr. VP & Chief Commercial Operations Officer (Age 63, Pay $571.28k)
  • Ms. Kristie Stephens, Chief Compliance Officer & VP of Regulatory Affairs
  • Mr. Grant Brock, VP of Operations

What is Timothy Crew's approval rating as Lannett's CEO?

9 employees have rated Lannett CEO Timothy Crew on Glassdoor.com. Timothy Crew has an approval rating of 28% among Lannett's employees. This puts Timothy Crew in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include (CELG), Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $0.57.

How much money does Lannett make?

Lannett (NYSE:LCI) has a market capitalization of $24.74 million and generates $478.78 million in revenue each year. The company earns $-363,480,000.00 in net income (profit) each year or ($7.93) on an earnings per share basis.

How many employees does Lannett have?

Lannett employs 810 workers across the globe.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The official website for Lannett is www.lannett.com. The company can be reached via phone at (215) 333-9000 or via fax at 215-333-9004.

This page (NYSE:LCI) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.